Author

Joana Revés

WHAT IS THE REAL IMPACT OF THE HLA-DQA1*05 POLYMORPHISM ON INFLIXIMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE?
WHAT IS THE REAL IMPACT OF THE HLA-DQA1*05 POLYMORPHISM ON INFLIXIMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE?

Joana Revés  et al.

ABC SCORE TO PREDICT LOWER GASTROINTESTINAL BLEEDING SEVERITY: A STEP IN THE RIGHT DIRECTION
ABC SCORE TO PREDICT LOWER GASTROINTESTINAL BLEEDING SEVERITY: A STEP IN THE RIGHT DIRECTION

EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?
EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?

Joana Revés  et al.

ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?
ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?

Joana Revés  et al.

SEVERE COLITIS FOLLOWING RITUXIMAB THERAPY: A RARE ENTITY
SEVERE COLITIS FOLLOWING RITUXIMAB THERAPY: A RARE ENTITY

DISAGREEMENT BETWEEN ENDOSCOPIC AND TRANSMURAL HEALING IN CROHN’S DISEASE AND THE IMPACT OF DISEASE DURATION
DISAGREEMENT BETWEEN ENDOSCOPIC AND TRANSMURAL HEALING IN CROHN’S DISEASE AND THE IMPACT OF DISEASE DURATION

Joana Revés  et al.

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

Joana Revés

NEUTROPHIL TO LYMPHOCYTE RATIO TO PREDICT SEVERITY IN ACUTE PANCREATITIS: HOW DOES IT COMPARE WITH OTHER PROGNOSTIC SCORES
NEUTROPHIL TO LYMPHOCYTE RATIO TO PREDICT SEVERITY IN ACUTE PANCREATITIS: HOW DOES IT COMPARE WITH OTHER PROGNOSTIC SCORES

Joana Revés  et al.

ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?
ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?

SEVERE COLITIS FOLLOWING RITUXIMAB THERAPY: A RARE ENTITY
SEVERE COLITIS FOLLOWING RITUXIMAB THERAPY: A RARE ENTITY

Joana Revés  et al.

EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?
EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?

ABC SCORE TO PREDICT LOWER GASTROINTESTINAL BLEEDING SEVERITY: A STEP IN THE RIGHT DIRECTION
ABC SCORE TO PREDICT LOWER GASTROINTESTINAL BLEEDING SEVERITY: A STEP IN THE RIGHT DIRECTION

Joana Revés  et al.

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

Joana Revés  et al.

SECONDARY SCLEROSING CHOLANGITIS IN A CRITICALLY-ILL PATIENT PRECIPITATED BY SARS-COV2 INFECTION
SECONDARY SCLEROSING CHOLANGITIS IN A CRITICALLY-ILL PATIENT PRECIPITATED BY SARS-COV2 INFECTION

Joana Revés  et al.

NBI FOR THE DETECTION OF SESSILE SERRATED LESIONS: A RANDOMIZED CONTROLLED TRIAL
NBI FOR THE DETECTION OF SESSILE SERRATED LESIONS: A RANDOMIZED CONTROLLED TRIAL

Joana Revés  et al.

LESS IS MORE: THE IMPACT OF 2020 ESGE GUIDELINE ON POST PIECEMEAL EMR SURVEILLANCE
LESS IS MORE: THE IMPACT OF 2020 ESGE GUIDELINE ON POST PIECEMEAL EMR SURVEILLANCE

Joana Revés  et al.

RADIATION DOSE OPTIMIZATION IN ERCP: PROSPECTIVE INTERVENTIONAL STUDY
RADIATION DOSE OPTIMIZATION IN ERCP: PROSPECTIVE INTERVENTIONAL STUDY

Joana Revés  et al.

HOW DO HOSPITALIZED PATIENTS WITH CHRONIC LIVER DISEASE DIE? - END-OF-LIFE QUALITY ANALYSIS
HOW DO HOSPITALIZED PATIENTS WITH CHRONIC LIVER DISEASE DIE? - END-OF-LIFE QUALITY ANALYSIS

Joana Revés  et al.

MAINTENANCE THERAPY AFTER AN EPISODE OF STEROID-RESPONSIVE ACUTE SEVERE ULCERATIVE COLITIS: WHAT IS THE BEST STRATEGY?
MAINTENANCE THERAPY AFTER AN EPISODE OF STEROID-RESPONSIVE ACUTE SEVERE ULCERATIVE COLITIS: WHAT IS THE BEST STRATEGY?

Joana Revés  et al.

Item 1 - 20 / 22
1
2